HEADER MEMBRANE PROTEIN 30-MAY-25 9V8Y TITLE MEMBRANE PROTEIN S6A8 APO COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM- AND CHLORIDE-DEPENDENT CREATINE TRANSPORTER 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CT1,CREATINE TRANSPORTER 1,SOLUTE CARRIER FAMILY 6 MEMBER 8; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A8; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS MEMBRANE PROTEIN S6A8 APO, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.S.ZHANG REVDAT 1 15-APR-26 9V8Y 0 JRNL AUTH X.YUAN,J.YIN,C.LIU,X.CHEN,M.CHEN,Y.WANG,Z.YANG,Y.WANG, JRNL AUTH 2 L.JIANG,N.ZHOU,X.WANG,B.LIU,Z.MA,K.WANG,H.LI,S.ZHANG, JRNL AUTH 3 Y.SHANG,M.YANG JRNL TITL STRUCTURAL INSIGHTS INTO THE SUBSTRATE UPTAKE AND INHIBITION JRNL TITL 2 OF THE HUMAN CREATINE TRANSPORTER (HCRT). JRNL REF PROC.NATL.ACAD.SCI.USA V. 122 35122 2025 JRNL REFN ESSN 1091-6490 JRNL PMID 40892912 JRNL DOI 10.1073/PNAS.2426135122 REMARK 2 REMARK 2 RESOLUTION. 3.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.280 REMARK 3 NUMBER OF PARTICLES : 132400 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9V8Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 05-JUN-25. REMARK 100 THE DEPOSITION ID IS D_1300060047. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : MEMBRANE PROTEIN S6A8 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOCONTINUUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 LYS A 3 REMARK 465 LYS A 4 REMARK 465 SER A 5 REMARK 465 ALA A 6 REMARK 465 GLU A 7 REMARK 465 ASN A 8 REMARK 465 GLY A 9 REMARK 465 ILE A 10 REMARK 465 TYR A 11 REMARK 465 SER A 12 REMARK 465 VAL A 13 REMARK 465 SER A 14 REMARK 465 GLY A 15 REMARK 465 ASP A 16 REMARK 465 GLU A 17 REMARK 465 LYS A 18 REMARK 465 LYS A 19 REMARK 465 GLY A 20 REMARK 465 PRO A 21 REMARK 465 LEU A 22 REMARK 465 ILE A 23 REMARK 465 ALA A 24 REMARK 465 PRO A 25 REMARK 465 GLY A 26 REMARK 465 PRO A 27 REMARK 465 ASP A 28 REMARK 465 GLY A 29 REMARK 465 ALA A 30 REMARK 465 PRO A 31 REMARK 465 ALA A 32 REMARK 465 LYS A 33 REMARK 465 GLY A 34 REMARK 465 ASP A 35 REMARK 465 GLY A 36 REMARK 465 PRO A 37 REMARK 465 VAL A 38 REMARK 465 GLY A 39 REMARK 465 LEU A 40 REMARK 465 GLY A 41 REMARK 465 THR A 42 REMARK 465 PRO A 43 REMARK 465 GLY A 44 REMARK 465 GLY A 45 REMARK 465 ARG A 46 REMARK 465 LEU A 47 REMARK 465 ALA A 48 REMARK 465 VAL A 49 REMARK 465 PRO A 50 REMARK 465 PRO A 51 REMARK 465 ARG A 52 REMARK 465 GLU A 53 REMARK 465 THR A 54 REMARK 465 TRP A 55 REMARK 465 TRP A 169 REMARK 465 ALA A 170 REMARK 465 THR A 171 REMARK 465 CYS A 172 REMARK 465 GLY A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 TRP A 176 REMARK 465 ASN A 177 REMARK 465 THR A 178 REMARK 465 PRO A 179 REMARK 465 ASP A 180 REMARK 465 CYS A 181 REMARK 465 VAL A 182 REMARK 465 GLU A 183 REMARK 465 ILE A 184 REMARK 465 PHE A 185 REMARK 465 ARG A 186 REMARK 465 HIS A 187 REMARK 465 GLU A 188 REMARK 465 ASP A 189 REMARK 465 CYS A 190 REMARK 465 ALA A 191 REMARK 465 ASN A 192 REMARK 465 ALA A 193 REMARK 465 SER A 194 REMARK 465 LEU A 195 REMARK 465 ALA A 196 REMARK 465 ASN A 197 REMARK 465 LEU A 198 REMARK 465 THR A 199 REMARK 465 CYS A 200 REMARK 465 ASP A 201 REMARK 465 GLN A 202 REMARK 465 LEU A 203 REMARK 465 ALA A 204 REMARK 465 VAL A 254 REMARK 465 LYS A 255 REMARK 465 SER A 256 REMARK 465 LEU A 282 REMARK 465 PRO A 283 REMARK 465 LEU A 433 REMARK 465 PRO A 434 REMARK 465 ALA A 435 REMARK 465 SER A 436 REMARK 465 TYR A 437 REMARK 465 TYR A 438 REMARK 465 PHE A 439 REMARK 465 ARG A 440 REMARK 465 PHE A 441 REMARK 465 ARG A 582 REMARK 465 ALA A 583 REMARK 465 LYS A 584 REMARK 465 GLY A 585 REMARK 465 THR A 586 REMARK 465 MET A 587 REMARK 465 ALA A 588 REMARK 465 GLU A 589 REMARK 465 ARG A 590 REMARK 465 TRP A 591 REMARK 465 GLN A 592 REMARK 465 HIS A 593 REMARK 465 LEU A 594 REMARK 465 THR A 595 REMARK 465 GLN A 596 REMARK 465 PRO A 597 REMARK 465 ILE A 598 REMARK 465 TRP A 599 REMARK 465 GLY A 600 REMARK 465 LEU A 601 REMARK 465 HIS A 602 REMARK 465 HIS A 603 REMARK 465 LEU A 604 REMARK 465 GLU A 605 REMARK 465 TYR A 606 REMARK 465 ARG A 607 REMARK 465 ALA A 608 REMARK 465 GLN A 609 REMARK 465 ASP A 610 REMARK 465 ALA A 611 REMARK 465 ASP A 612 REMARK 465 VAL A 613 REMARK 465 ARG A 614 REMARK 465 GLY A 615 REMARK 465 LEU A 616 REMARK 465 THR A 617 REMARK 465 THR A 618 REMARK 465 LEU A 619 REMARK 465 THR A 620 REMARK 465 PRO A 621 REMARK 465 VAL A 622 REMARK 465 SER A 623 REMARK 465 GLU A 624 REMARK 465 SER A 625 REMARK 465 SER A 626 REMARK 465 LYS A 627 REMARK 465 VAL A 628 REMARK 465 VAL A 629 REMARK 465 VAL A 630 REMARK 465 VAL A 631 REMARK 465 GLU A 632 REMARK 465 SER A 633 REMARK 465 VAL A 634 REMARK 465 MET A 635 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 80 OD2 ASP A 474 2.07 REMARK 500 O VAL A 100 OG1 THR A 527 2.08 REMARK 500 OH TYR A 317 OG SER A 349 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 303 CA - N - CD ANGL. DEV. = -9.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 79 42.63 -84.09 REMARK 500 TRP A 124 34.07 -91.56 REMARK 500 PRO A 228 42.84 -85.22 REMARK 500 PRO A 303 -19.74 -46.39 REMARK 500 ASN A 334 37.35 -98.02 REMARK 500 ASN A 335 -167.69 -79.02 REMARK 500 ALA A 385 -5.32 80.18 REMARK 500 THR A 463 -75.86 -62.44 REMARK 500 ASP A 464 -24.29 -144.31 REMARK 500 ASN A 549 13.53 58.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 79 TYR A 80 145.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-64855 RELATED DB: EMDB REMARK 900 MEMBRANE PROTEIN S6A8 APO DBREF 9V8Y A 1 635 UNP P48029 SC6A8_HUMAN 1 635 SEQRES 1 A 635 MET ALA LYS LYS SER ALA GLU ASN GLY ILE TYR SER VAL SEQRES 2 A 635 SER GLY ASP GLU LYS LYS GLY PRO LEU ILE ALA PRO GLY SEQRES 3 A 635 PRO ASP GLY ALA PRO ALA LYS GLY ASP GLY PRO VAL GLY SEQRES 4 A 635 LEU GLY THR PRO GLY GLY ARG LEU ALA VAL PRO PRO ARG SEQRES 5 A 635 GLU THR TRP THR ARG GLN MET ASP PHE ILE MET SER CYS SEQRES 6 A 635 VAL GLY PHE ALA VAL GLY LEU GLY ASN VAL TRP ARG PHE SEQRES 7 A 635 PRO TYR LEU CYS TYR LYS ASN GLY GLY GLY VAL PHE LEU SEQRES 8 A 635 ILE PRO TYR VAL LEU ILE ALA LEU VAL GLY GLY ILE PRO SEQRES 9 A 635 ILE PHE PHE LEU GLU ILE SER LEU GLY GLN PHE MET LYS SEQRES 10 A 635 ALA GLY SER ILE ASN VAL TRP ASN ILE CYS PRO LEU PHE SEQRES 11 A 635 LYS GLY LEU GLY TYR ALA SER MET VAL ILE VAL PHE TYR SEQRES 12 A 635 CYS ASN THR TYR TYR ILE MET VAL LEU ALA TRP GLY PHE SEQRES 13 A 635 TYR TYR LEU VAL LYS SER PHE THR THR THR LEU PRO TRP SEQRES 14 A 635 ALA THR CYS GLY HIS THR TRP ASN THR PRO ASP CYS VAL SEQRES 15 A 635 GLU ILE PHE ARG HIS GLU ASP CYS ALA ASN ALA SER LEU SEQRES 16 A 635 ALA ASN LEU THR CYS ASP GLN LEU ALA ASP ARG ARG SER SEQRES 17 A 635 PRO VAL ILE GLU PHE TRP GLU ASN LYS VAL LEU ARG LEU SEQRES 18 A 635 SER GLY GLY LEU GLU VAL PRO GLY ALA LEU ASN TRP GLU SEQRES 19 A 635 VAL THR LEU CYS LEU LEU ALA CYS TRP VAL LEU VAL TYR SEQRES 20 A 635 PHE CYS VAL TRP LYS GLY VAL LYS SER THR GLY LYS ILE SEQRES 21 A 635 VAL TYR PHE THR ALA THR PHE PRO TYR VAL VAL LEU VAL SEQRES 22 A 635 VAL LEU LEU VAL ARG GLY VAL LEU LEU PRO GLY ALA LEU SEQRES 23 A 635 ASP GLY ILE ILE TYR TYR LEU LYS PRO ASP TRP SER LYS SEQRES 24 A 635 LEU GLY SER PRO GLN VAL TRP ILE ASP ALA GLY THR GLN SEQRES 25 A 635 ILE PHE PHE SER TYR ALA ILE GLY LEU GLY ALA LEU THR SEQRES 26 A 635 ALA LEU GLY SER TYR ASN ARG PHE ASN ASN ASN CYS TYR SEQRES 27 A 635 LYS ASP ALA ILE ILE LEU ALA LEU ILE ASN SER GLY THR SEQRES 28 A 635 SER PHE PHE ALA GLY PHE VAL VAL PHE SER ILE LEU GLY SEQRES 29 A 635 PHE MET ALA ALA GLU GLN GLY VAL HIS ILE SER LYS VAL SEQRES 30 A 635 ALA GLU SER GLY PRO GLY LEU ALA PHE ILE ALA TYR PRO SEQRES 31 A 635 ARG ALA VAL THR LEU MET PRO VAL ALA PRO LEU TRP ALA SEQRES 32 A 635 ALA LEU PHE PHE PHE MET LEU LEU LEU LEU GLY LEU ASP SEQRES 33 A 635 SER GLN PHE VAL GLY VAL GLU GLY PHE ILE THR GLY LEU SEQRES 34 A 635 LEU ASP LEU LEU PRO ALA SER TYR TYR PHE ARG PHE GLN SEQRES 35 A 635 ARG GLU ILE SER VAL ALA LEU CYS CYS ALA LEU CYS PHE SEQRES 36 A 635 VAL ILE ASP LEU SER MET VAL THR ASP GLY GLY MET TYR SEQRES 37 A 635 VAL PHE GLN LEU PHE ASP TYR TYR SER ALA SER GLY THR SEQRES 38 A 635 THR LEU LEU TRP GLN ALA PHE TRP GLU CYS VAL VAL VAL SEQRES 39 A 635 ALA TRP VAL TYR GLY ALA ASP ARG PHE MET ASP ASP ILE SEQRES 40 A 635 ALA CYS MET ILE GLY TYR ARG PRO CYS PRO TRP MET LYS SEQRES 41 A 635 TRP CYS TRP SER PHE PHE THR PRO LEU VAL CYS MET GLY SEQRES 42 A 635 ILE PHE ILE PHE ASN VAL VAL TYR TYR GLU PRO LEU VAL SEQRES 43 A 635 TYR ASN ASN THR TYR VAL TYR PRO TRP TRP GLY GLU ALA SEQRES 44 A 635 MET GLY TRP ALA PHE ALA LEU SER SER MET LEU CYS VAL SEQRES 45 A 635 PRO LEU HIS LEU LEU GLY CYS LEU LEU ARG ALA LYS GLY SEQRES 46 A 635 THR MET ALA GLU ARG TRP GLN HIS LEU THR GLN PRO ILE SEQRES 47 A 635 TRP GLY LEU HIS HIS LEU GLU TYR ARG ALA GLN ASP ALA SEQRES 48 A 635 ASP VAL ARG GLY LEU THR THR LEU THR PRO VAL SER GLU SEQRES 49 A 635 SER SER LYS VAL VAL VAL VAL GLU SER VAL MET HET CL A 701 1 HETNAM CL CHLORIDE ION FORMUL 2 CL CL 1- HELIX 1 AA1 CYS A 65 VAL A 70 1 6 HELIX 2 AA2 ARG A 77 ASN A 85 1 9 HELIX 3 AA3 PHE A 90 LEU A 99 1 10 HELIX 4 AA4 GLY A 102 MET A 116 1 15 HELIX 5 AA5 LEU A 129 LYS A 131 5 3 HELIX 6 AA6 GLY A 132 CYS A 144 1 13 HELIX 7 AA7 TYR A 147 LYS A 161 1 15 HELIX 8 AA8 SER A 208 LYS A 217 1 10 HELIX 9 AA9 GLU A 234 LEU A 239 1 6 HELIX 10 AB1 LEU A 239 PHE A 248 1 10 HELIX 11 AB2 THR A 266 LEU A 276 1 11 HELIX 12 AB3 LEU A 286 LYS A 294 1 9 HELIX 13 AB4 ASP A 296 GLY A 301 5 6 HELIX 14 AB5 SER A 302 TYR A 317 1 16 HELIX 15 AB6 ASP A 340 GLY A 371 1 32 HELIX 16 AB7 ILE A 387 MET A 396 1 10 HELIX 17 AB8 VAL A 398 LEU A 430 1 33 HELIX 18 AB9 ILE A 445 ILE A 457 1 13 HELIX 19 AC1 ASP A 458 MET A 461 5 4 HELIX 20 AC2 GLY A 466 TYR A 476 1 11 HELIX 21 AC3 GLY A 480 CYS A 491 1 12 HELIX 22 AC4 GLY A 499 ALA A 508 1 10 HELIX 23 AC5 MET A 519 SER A 524 1 6 HELIX 24 AC6 PHE A 526 TYR A 541 1 16 HELIX 25 AC7 ASN A 548 THR A 550 5 3 HELIX 26 AC8 PRO A 554 LEU A 570 1 17 HELIX 27 AC9 LEU A 570 LEU A 581 1 12 SHEET 1 AA1 2 VAL A 546 TYR A 547 0 SHEET 2 AA1 2 TYR A 551 VAL A 552 -1 O TYR A 551 N TYR A 547 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 334 0 1 27 2 0 0 6 3766 1 0 49 END